Overview of magnetic resonance lymphography for imaging lymphoedema

Abstract

Lymphoedema is a chronic and debilitating condition commonly caused by cancer therapies, including lymph node dissection and radiotherapy in developed countries. A range of imaging modalities is used to view the lymphatic system for proper diagnosis, staging, and management of lymphoedema. Lymphoscintigraphy is the current gold standard imaging modality of the lymphatic system. However, magnetic resonance lymphography (MRL) is showing potential benefits in lymphoedema assessment and surgical planning. A literature review was compiled from published articles, incorporating their background literature, research outcomes, and recommendations to review the technique, application, and limitations of MRL. MRL is minimally invasive with no ionizing radiation, providing both functional and anatomical details of the lymphatic system with a higher spatial resolution than conventional lymphoscintigraphy. It shows promising results in the staging, surgical work-up, and surveillance for individuals with both primary and secondary lymphoedema.

Keywords

Magnetic resonance lymphography / lymphangiography / lymphoedema / lymphatic system / imaging

References

[1] Mazzei FG,Guerrini S.MR lymphangiography: a practical guide to perform it and a brief review of the literature from a technical point of view.Biomed Res Int2017;2017:2598358 PMCID:PMC5359436

[2] Mitsumori LM,Wilson GJ,Minoshima S.MR lymphangiography: how I do it.J Magn Reson Imaging2015;42:1465-77

[3] Mazzei MA,Mazzei FG.High-resolution MR lymphangiography for planning lymphaticovenous anastomosis treatment: a single-centre experience.Radiol Med2017;122:918-27

[4] Liu NF,Wu XF.Magnetic resonance lymphography demonstrates spontaneous lymphatic disruption and regeneration in obstructive lymphedema.Lymphology2013;46:56-63

[5] Chang DW,Skoracki R.A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.Plast Reconstr Surg2013;132:1305-14

[6] Mitsumori LM,Neligan PC.Peripheral magnetic resonance lymphangiography: techniques and applications.Tech Vasc Interv Radiol2016;19:262-72

[7] White RD,Budak MJ,Munnoch DA.Contrast-enhanced magnetic resonance lymphography in the assessment of lower limb lymphoedema.Clin Radiol2014;69:e435-44

[8] Cellina M,Menozzi A,Martinenghi C.Non-contrast magnetic resonance lymphangiography: an emerging technique for the study of lymphedema.Clin Imaging2019;53:126-33

[9] Cellina M,Floridi C.Volumetric analysis of non-contrast magnetic resonance lymphangiography in patients affected by lower extremities primary lymphedema.Radiol Med2020;125:432-5

[10] Nagase T,Inoue K.Treatment of lymphedema with lymphaticovenular anastomoses.Int J Clin Oncol2005;10:304-10

[11] Long X,Zhang D.Microsurgery guided by sequential preoperative lymphography using ⁶⁸Ga-NEB PET and MRI in patients with lower-limb lymphedema.Eur J Nucl Med Mol Imaging2017;44:1501-10 PMCID:PMC5507721

[12] Linnitt N.Lymphoedema: recognition, assessment and management.Br J Community Nurs2005;10:S20-6

[13] Liu NF,Liu PA,Wang BS.Comparison of radionuclide lymphoscintigraphy and dynamic magnetic resonance lymphangiography for investigating extremity lymphoedema.Br J Surg2010;97:359-65

[14] Lu Q,Liu N.Chronic lower extremity lymphedema: a comparative study of high-resolution interstitial MR lymphangiography and heavily T2-weighted MRI.Eur J Radiol2010;73:365-73

[15] Liu NF,Jiang ZH,Zhou JG.Anatomic and functional evaluation of the lymphatics and lymph nodes in diagnosis of lymphatic circulation disorders with contrast magnetic resonance lymphangiography.J Vasc Surg2009;49:980-7

[16] Lohrmann C,Bartholomä JP.MR imaging of the lymphatic system: distribution and contrast enhancement of gadodiamide after intradermal injection.Lymphology2006;39:156-63

[17] Lu Q,Liu NF,Zhao XH.Magnetic resonance lymphography at 3T: a promising noninvasive approach to characterise inguinal lymphatic vessel leakage.Eur J Vasc Endovasc Surg2012;43:106-11

[18] Baz AA,Atta A.Role of contrast enhanced MRI lymphangiography in evaluation of lower extremity lymphatic vessels for patients with primary lymphedema.The Egyptian Journal of Radiology and Nuclear Medicine2018;49:776-81

[19] Arrivé L,Dahan B.Primary lower limb lymphoedema: classification with non-contrast MR lymphography.Eur Radiol2018;28:291-300

[20] Arrivé L,Dlimi C,Monnier-Cholley L.Noncontrast magnetic resonance lymphography for evaluation of lymph node transfer for secondary upper limb lymphedema.Plast Reconstr Surg2017;140:806e-11e

[21] Arrivé L,El Mouhadi S,Menu Y.Noncontrast magnetic resonance lymphography.J Reconstr Microsurg2016;32:80-6

[22] Notohamiprodjo M,Jakobs TF.MR-lymphangiography at 3.0 T--a feasibility study.Eur Radiol2009;19:2771-8

[23] Lu Q,Hu A.MR lymphography of lymphatic vessels in lower extremity with gynecologic oncology-related lymphedema.PLoS One2012;7:e50319 PMCID:PMC3509000

[24] Bae JS,Choi SH.Evaluation of lymphedema in upper extremities by MR lymphangiography: Comparison with lymphoscintigraphy.Magn Reson Imaging2018;49:63-70

[25] Liu N.Magnetic Resonance lymphangiography for the study of lymphatic System in lymphedema.J Reconstr Microsurg2016;32:66-71

[26] Lohrmann C,Speck O.High-resolution MR lymphangiography in patients with primary and secondary lymphedema.AJR Am J Roentgenol2006;187:556-61

[27] Liu NF,Wu XF.Classification of lymphatic-system malformations in primary lymphoedema based on MR lymphangiography.Eur J Vasc Endovasc Surg2012;44:345-9

[28] Zeltzer AA,Koning M.MR lymphography in patients with upper limb lymphedema: The GPS for feasibility and surgical planning for lympho-venous bypass.J Surg Oncol2018;118:407-15

[29] Liu NF.Functional lymphatic collectors in breast cancer-related lymphedema arm.Lymphat Res Biol2014;12:232-7 PMCID:PMC4267712

[30] Maki JH,Briller N,Wilson GJ.Dark blood magnetic resonance lymphangiography using dual-agent relaxivity contrast (DARC-MRL): a novel method combining gadolinium and iron contrast agents.Curr Probl Diagn Radiol2016;45:174-9

[31] Liu N,Sun M.Noncontrast three-dimensional magnetic resonance imaging vs lymphoscintigraphy in the evaluation of lymph circulation disorders: a comparative study.J Vasc Surg2005;41:69-75

[32] Borri M,Hughes JC.Magnetic resonance imaging-based assessment of breast cancer-related lymphoedema tissue composition.Invest Radiol2017;52:554-61 PMCID:PMC5548500

[33] Shinaoka A,Yamada K.Correlations between tracer injection sites and lymphatic pathways in the leg: a near-infrared fluorescence lymphography study.Plast Reconstr Surg2019;144:634-42

[34] Clough RE.Magnetic resonance imaging to guide surgical practice.Eur J Vasc Endovasc Surg2012;43:112-3

[35] Torres Lacomba M,Zapico Goñi A.Effectiveness of early physiotherapy to prevent lymphoedema after surgery for breast cancer: randomised, single blinded, clinical trial.BMJ2010;340:b5396 PMCID:PMC2806631

[36] Mihara M,Araki J.Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of early lymphedema of the upper limbs.PLoS One2012;7:e38182 PMCID:PMC3366958

[37] Becker C,Riquet M.Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation.Ann Surg2006;243:313-5 PMCID:PMC1448940

[38] Lin CH,Chen SC.Vascularized groin lymph node transfer using the wrist as a recipient site for management of postmastectomy upper extremity lymphedema.Plast Reconstr Surg2009;123:1265-75

[39] Brorson H.Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer.Acta Oncol2000;39:407-20

[40] Brorson H.Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than controlled compression therapy alone.Plast Reconstr Surg1998;102:1058-67; discussion 1068

[41] Ridner SH,Cowher MS.A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis.Ann Surg Oncol2019;26:3250-9 PMCID:PMC6733825

[42] Semelka RC,Jay M.Summary of special issue on gadolinium bioeffects and toxicity with a look to the future.Magn Reson Imaging2016;34:1399-401

[43] Guideline on the use of gadolinium-containing MRI contrast agents in patient with renal impairment, Version 3. 2019, The Royal Australian and New Zealand College of Radiologists. Available from: https://www.ranzcr.com/documents/553-revised-college-guidelines-for-gadolinium-containing-mri-contrast-agents/file. [Last accessed on 5 Aug 2021]

[44] Gulani V,Shellock FG,Reeder SB.Gadolinium deposition in the brain: summary of evidence and recommendations.Lancet Neurol2017;16:564-70

[45] Murata N,Gonzalez-Cuyar LF.Gadolinium tissue deposition in brain and bone.Magn Reson Imaging2016;34:1359-65

[46] FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new class warnings. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-gadolinium-based-contrast-agents-gbcas-are-retained-body. [Last accessed on 5 Aug 2021]

[47] Miseré RML,Lobbes MBI,Qiu SS.A systematic review of magnetic resonance lymphography for the evaluation of peripheral lymphedema.J Vasc Surg Venous Lymphat Disord2020;8:882-92.e2